Cargando…

Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings

BACKGROUND: Chronic kidney disease (CKD) typically co-exists with multimorbidity (presence of 2 or more long-term conditions: LTCs). The associations between CKD, multimorbidity and hospitalisation rates are not known. The aim of this study was to examine hospitalisation rates in people with multimo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sullivan, Michael K., Jani, Bhautesh Dinesh, McConnachie, Alex, Hanlon, Peter, McLoone, Philip, Nicholl, Barbara I., Carrero, Juan-Jesus, Nitsch, Dorothea, McAllister, David, Mair, Frances S., Mark, Patrick B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603496/ https://www.ncbi.nlm.nih.gov/pubmed/34794437 http://dx.doi.org/10.1186/s12916-021-02147-6

Ejemplares similares

The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
por: Sullivan, Michael K., et al.
Publicado: (2022)

Prevalence of chronic pain in LTCs and multimorbidity: A cross-sectional study using UK Biobank
por: McQueenie, Ross, et al.
Publicado: (2021)

Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies
por: Hanlon, Peter, et al.
Publicado: (2022)

An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes
por: Hanlon, Peter, et al.
Publicado: (2021)

Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort
por: Sullivan, Michael K, et al.
Publicado: (2021)

Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study
por: Sullivan, Michael K, et al.
Publicado: (2022)

Frailty in rheumatoid arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants
por: Hanlon, Peter, et al.
Publicado: (2018)

Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2019)

Challenges and Implications of Routine Depression Screening for Depression in Chronic Disease and Multimorbidity: A Cross Sectional Study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2013)

Long-term conditions, multimorbidity and colorectal cancer risk in the UK Biobank cohort
por: Corcoran, Neave ME, et al.
Publicado: (2022)

Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2018)

Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study
por: Hanlon, Peter, et al.
Publicado: (2018)

Classification of long-term condition patterns in rheumatoid arthritis and associations with adverse health events: a UK Biobank cohort study
por: McLoone, Philip, et al.
Publicado: (2023)

Association between childhood maltreatment and the prevalence and complexity of multimorbidity: A cross-sectional analysis of 157,357 UK Biobank participants
por: Hanlon, Peter, et al.
Publicado: (2020)

Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Risk Factors and Mortality Associated with Multimorbidity in People with Stroke or Transient Ischaemic Attack: A Study of 8,751 UK Biobank Participants
por: Gallacher, Katie I., et al.
Publicado: (2018)

Examining the relationship between rheumatoid arthritis, multimorbidity and adverse health-related outcomes: A systematic review protocol
por: Canning, Jordan, et al.
Publicado: (2020)

Frailty in people with rheumatoid arthritis: a systematic review of observational studies
por: Hanlon, Peter, et al.
Publicado: (2022)

Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants
por: McQueenie, Ross, et al.
Publicado: (2020)

Association between patterns of alcohol consumption (beverage type, frequency and consumption with food) and risk of adverse health outcomes: a prospective cohort study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2021)

Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review
por: Chiang, Jason I., et al.
Publicado: (2018)

Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts
por: Chiang, Jason I., et al.
Publicado: (2020)

Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice
por: Chiang, Jason I, et al.
Publicado: (2020)

Impact of multimorbidity count on all-cause mortality and glycaemic outcomes in people with type 2 diabetes: a systematic review protocol
por: Chiang, Jason I, et al.
Publicado: (2018)

Comorbidity versus multimorbidity: Why it matters
por: Harrison, Christopher, et al.
Publicado: (2021)

Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis
por: Sullivan, Michael K., et al.
Publicado: (2020)

Associations between long-term conditions and upper gastrointestinal cancer incidence: A prospective population-based cohort of UK Biobank participants
por: Marley, Jennifer, et al.
Publicado: (2021)

The incidence and body site of skin cancers in the population groups of Astana, Kazakhstan
por: McLoone, Pauline, et al.
Publicado: (2018)

COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study
por: Hanlon, Peter, et al.
Publicado: (2021)

Chronic pain and COVID-19 hospitalisation and mortality: a UK Biobank cohort study
por: Hastie, Claire E., et al.
Publicado: (2023)

Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
por: Hanlon, Peter, et al.
Publicado: (2019)

Multimorbidity and the COVID-19 pandemic – An urgent call to action
por: Mair, Frances S, et al.
Publicado: (2020)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)

Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care
por: Bidulka, Patrick, et al.
Publicado: (2020)

Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2021)

Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers
por: Jani, Bhautesh D., et al.
Publicado: (2015)

The lifetime prevalence of hospitalised head injury in Scottish prisons: A population study
por: McMillan, T. M., et al.
Publicado: (2019)

The effects of anti-depressants on depression symptom scores at 12 months follow-up in patients with cardiometabolic disease: Results from a large primary care cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2015)

Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPD
por: Hanlon, Peter, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rblb72g9qbrj2bjrds7r5d4lkb